All importers of Medicines are hereby informed that, in response to your feedback and to facilitate the process, the National Medicines Regulatory Authority decided to offer an alternative method for submitting import data.
Local agents who find it difficult to submit details via the Google form are hereby instructed to utilize the attached format. Please fill out the details according to the given format in an Excel sheet with the necessary details for each Medicine imported during the mentioned period and send the Excel sheet to This email address is being protected from spambots. You need JavaScript enabled to view it. with the subject line : "Collection of Import Data - Medicines."
Important Note :
- Please do not include details of medicines which have already been submitted via the Google Form.
- Each local agent is requested to submit only one Excel sheet containing the import data for all medicines.
Your corperation in this matter is greatly appreciated.
CEO,
NMRA
- විස්තර
All Marketing authorization holders / Local manufacturers of medicine are hereby informed that the e-mail address for the notification of Drug Master File (DMF) of Active Pharmaceuticl Agent (API) is "This email address is being protected from spambots. You need JavaScript enabled to view it.".
The hard copy of e-mail sent by the manufacturer should be attached with the relevant dossier of the product.
- විස්තර
To all Marketing Authorization Holders of Medicines,
NMRA is publishing herewith a link to obtain Agency transferred dossier details pending at NMRA.
Please provide the required details on or before 20th of May 2024.
Click on the link below or scan the QR code to fill the Google Form.
- විස්තර
To all Market Authorization Holders of Medicines,
NMRA is publishing herewith a link to obtain Manufacturing site changed dossier (Sterile & Non-sterile medicines) details pending at NMRA. (Please note that if you already submitted these details via the link which was published in Feb 2024, no need to fill this form again.)
Please provide required details on or before 15 th May 2024.
- විස්තර